NOX1 and neoplasm: Due to the evidence that indicates high NOX1 levels in HCC that correlate with a poor prognosis [155,157], as well as the involvement of NOX1 in tumor cell proliferation and migration [156] and macrophage-induced inflammation [38], different studies focused on the use of NOX1 inhibitors in experimental models of hepatocarcinogenesis.